Teamtrade Inc. – Trademark Portfolio
Entity Type: 03
Teamtrade Inc. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include SEROMEN, FLEXTIVA, SEROLIFE, SEROVERA, and SEROFLORA. The owner is based in Fort Lauderdale, FL.
2139 NE 56th Place
Fort Lauderdale, FL 33308
Showing of trademarks Trademarks
Trademark Classifications
Teamtrade Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Teamtrade Inc. have?
Teamtrade Inc. has 14 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 abandoned, 4 cancelled.
What trademark classes does Teamtrade Inc. file in?
Teamtrade Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Teamtrade Inc.'s most well-known trademarks?
Teamtrade Inc.'s registered trademark portfolio includes well-known marks such as SEROMEN, FLEXTIVA, SEROLIFE, SEROVERA, and SEROFLORA. These are among 6 currently registered trademarks in the portfolio.
What is Teamtrade Inc.'s trademark registration success rate?
Teamtrade Inc. has a 43% trademark registration rate, with 6 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.